Jun 16, 2020
Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020
Jun 10, 2020
Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit
May 13, 2020
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months
Feb 21, 2020
Global Bispecific Antibody Therapeutics Market (2019 to 2030) - In-depth Analysis, Highlighting the Capabilities of Various Stakeholders Engaged in this Domain
Feb 18, 2020
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
Feb 11, 2020
The Antibody Contract Manufacturing Market is Projected to Reach USD 13.8 Billion by 2030, Growing at an Annualized Rate of 9.5%, Claims Roots Analysis
Feb 06, 2020
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
Feb 04, 2020
Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026
Jan 09, 2020
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
Jan 08, 2020
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
Jan 08, 2020
Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer Immunotherapy
Nov 06, 2019
Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting
Sep 16, 2019
Investigational Bispecific Therapeutic Antibodies: 2019 Landscape Evaluation Report
Sep 11, 2019
Applied BioMath, LLC Announces Participation at World Bispecific Summit
May 07, 2019
Absolute Antibody Launches Mouse Bispecific Antibody Reagents
Feb 25, 2019
Xencor Reports Fourth Quarter and Full Year 2018 Financial Results
Jan 18, 2019
Global Bispecific Antibody Market to 2025: Drug Sales & Clinical Pipeline Insights with an $8 Billion Market Opportunity
Jan 07, 2019
Alligator Bioscience Launches RUBY(TM), a Novel Concept in Bispecific Antibody Formats
Jan 03, 2019
ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
Dec 10, 2018
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Five Bispecific Antibody Programs for up to $450 Million